AION Diagnostics Inc, a nano-diagnostics company commercializing medical imaging agents, has announced the appointment of Theodor Dingermann, Ph.D. to its Scientific Advisory Board.
Professor Dingermann has over 30 years experience in the German pharmaceutical industry. He is the biotechnology advisor to the State of Hesse as well as Editor-in-chief of two leading German pharmaceutical journals; 'DIE PHARMAZIE' and 'Pharmazie in unserer Zeit.'
'We very much look forward to the expertise in molecular biology and biochemistry Prof. Dingermann will bring to AION, particularly to our Molecular Imaging platform,' said AION President and CEO, Dr. Anna Kluczewska.
Since 1990, Prof. Dingermann has been Full Professor of Pharmaceutical Biology at Goethe University in Frankfurt, Germany. He is Chairman of the working group of biopharmaceuticals and Vice-Chairman on pharmaceutical biology of the German Pharmacopeia Commission. From 2000 to 2004 he was President of the German Pharmaceutical Society. Prof. Dingermann studied Pharmacy at the University of Erlangen, Germany. On obtaining his Ph.D. in Biochemistry, he worked as a Post-Doctoral Research Fellow at Yale University, New Haven.
The AION Scientific Advisory Board is chartered to contribute independent scientific and strategic advice to the Company's operations.